![Patrick Yeramian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick Yeramian
Corporate Officer/Principal at Dlx Therapeutics L L C
Net worth: 390 650 $ as of 2024-06-29
Patrick Yeramian active positions
Companies | Position | Start | End |
---|---|---|---|
Dlx Therapeutics L L C | Corporate Officer/Principal | 2017-12-31 | - |
Career history of Patrick Yeramian
Former positions of Patrick Yeramian
Companies | Position | Start | End |
---|---|---|---|
AMYLYX PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2019-02-28 | 2023-11-27 |
BIOVIE INC. | Chief Tech/Sci/R&D Officer | 2018-10-31 | 2021-10-31 |
Kantum Pharma, Inc.
![]() Kantum Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Kantum Pharma, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for the prevention and treatment of damaging inflammation. The company was founded by Sylvie Breton and is headquartered in Concord, NH. | Chief Tech/Sci/R&D Officer | 2017-02-28 | 2019-02-28 |
MARKER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2015-01-31 | 2016-12-31 |
Tapimmune, Inc. | Chief Tech/Sci/R&D Officer | 2015-01-31 | 2016-12-31 |
Vaccine & Gene Therapy Institute of Florida Corp.
![]() Vaccine & Gene Therapy Institute of Florida Corp. Miscellaneous Commercial ServicesCommercial Services Vaccine & Gene Therapy Institute of Florida Corp. provides research services. The non-profit company is based in Port Saint Lucie, FL. | Chief Tech/Sci/R&D Officer | 2011-09-30 | 2015-01-31 |
Viragen, Inc.
![]() Viragen, Inc. BiotechnologyHealth Technology Viragen, Inc. is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. These protein-based drugs include natural human alpha interferon and monoclonal antibodies. Viragen's strategy also includes the development of Avian Transgenic Technology as a biomanufacturing platform for the large-scale, cost-effective production of therapeutic proteins. The firm is located in Plantation, FL. | Chief Tech/Sci/R&D Officer | 1998-05-31 | 2001-05-31 |
G.D. Searle LLC | Corporate Officer/Principal | 1993-05-31 | 1998-05-31 |
░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Training of Patrick Yeramian
Universite Paris Est Creteil Val De Marne | Doctorate Degree |
Rutgers Business School | Masters Business Admin |
Statistics
International
United States | 12 |
France | 3 |
Operational
Chief Tech/Sci/R&D Officer | 8 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 4 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
BIOVIE INC. | Health Technology |
PFIZER, INC. | Health Technology |
MARKER THERAPEUTICS, INC. | Health Technology |
AMYLYX PHARMACEUTICALS, INC. | Health Technology |
Private companies | 7 |
---|---|
Vaccine & Gene Therapy Institute of Florida Corp.
![]() Vaccine & Gene Therapy Institute of Florida Corp. Miscellaneous Commercial ServicesCommercial Services Vaccine & Gene Therapy Institute of Florida Corp. provides research services. The non-profit company is based in Port Saint Lucie, FL. | Commercial Services |
Université de Paris XI Paris Sud | Consumer Services |
Kantum Pharma, Inc.
![]() Kantum Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Kantum Pharma, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for the prevention and treatment of damaging inflammation. The company was founded by Sylvie Breton and is headquartered in Concord, NH. | Commercial Services |
Dlx Therapeutics L L C | |
Viragen, Inc.
![]() Viragen, Inc. BiotechnologyHealth Technology Viragen, Inc. is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. These protein-based drugs include natural human alpha interferon and monoclonal antibodies. Viragen's strategy also includes the development of Avian Transgenic Technology as a biomanufacturing platform for the large-scale, cost-effective production of therapeutic proteins. The firm is located in Plantation, FL. | Health Technology |
G.D. Searle LLC | |
Tapimmune, Inc. |
- Stock Market
- Insiders
- Patrick Yeramian
- Experience